{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:16:58Z","timestamp":1792880218253,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1097\/md.0000000000008133","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T16:21:01Z","timestamp":1506529261000},"page":"e8133","source":"Crossref","is-referenced-by-count":33,"title":["Botulinum toxin in the treatment of trigeminal neuralgia"],"prefix":"10.1097","volume":"96","author":[{"given":"\u00dclk\u00fc","family":"T\u00fcrk B\u00f6r\u00fc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arda","family":"Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"B\u00f6l\u00fck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanem","family":"Co\u015fkun Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ta\u015fdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-39-20210309","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pain.2006.01.030","article-title":"Epidemiology and treatment of neuropathic pain: the UK primary care perspective","volume":"122","author":"Hall","year":"2006","journal-title":"Pain"},{"key":"R2-39-20210309","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.pain.2008.03.002","article-title":"Incidence rates and treatment of neuropathic pain conditions in the general population","volume":"137","author":"Dieleman","year":"2008","journal-title":"Pain"},{"key":"R3-39-20210309","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.410270114","article-title":"Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945\u20131984","volume":"27","author":"Katusic","year":"1990","journal-title":"Ann Neurol"},{"key":"R4-39-20210309","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1468-1331.2008.02185.x","article-title":"AAN-EFNS guidelines on trigeminal neuralgia management","volume":"15","author":"Cruccu","year":"2008","journal-title":"Eur J Neurol"},{"key":"R5-39-20210309","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40263-012-0023-0","article-title":"Refractory trigeminal neuralgia","volume":"27","author":"Cruccu","year":"2013","journal-title":"CNS drugs"},{"key":"R6-39-20210309","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/pgmj.57.663.16","article-title":"Long-term treatment of trigeminal neuralgia with carbamazepine","volume":"57","author":"Taylor","year":"1981","journal-title":"Postgrad Med J"},{"key":"R7-39-20210309","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/00002508-200211001-00002","article-title":"Therapeutic use of botulinum toxins: background and history","volume":"18","author":"Setler","year":"2002","journal-title":"Clin J Pain"},{"key":"R8-39-20210309","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1054\/jpai.2002.27142","article-title":"The use of botulinum toxin for the treatment of chronic facial pain","volume":"3","author":"Borodic","year":"2002","journal-title":"Clin J Pain"},{"key":"R9-39-20210309","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/01.wnl.0000180940.98815.74","article-title":"An open study of botulinum-A toxin treatment of trigeminal neuralgia","volume":"65","author":"Piovesan","year":"2005","journal-title":"Neurology"},{"key":"R10-39-20210309","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.wnf.0000172497.24770.b0","article-title":"Botulinum toxin and intractable trigeminal neuralgia","volume":"28","author":"T\u00fcrk","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"R11-39-20210309","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1590\/S0004-282X2008000400012","article-title":"Beneficial effects of botulinum toxin type A in trigeminal neuralgia","volume":"66","author":"Z\u00fa\u00f1iga","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"R12-39-20210309","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.tripleo.2009.03.021","article-title":"Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain","volume":"109","author":"Ngeow","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R13-39-20210309","first-page":"9","article-title":"The international classification of headache disorders.","volume":"24","year":"2004","journal-title":"Cephalalgia"},{"key":"R14-39-20210309","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0333102412441721","article-title":"Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial","volume":"32","author":"Wu","year":"2012","journal-title":"Cephalalgia"},{"key":"R15-39-20210309","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3109\/00207454.2015.1019624","article-title":"Botulinum toxin a in the treatment of trigeminal neuralgia","volume":"126","author":"Xia","year":"2016","journal-title":"Int J Neurosci"},{"key":"R16-39-20210309","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13063-015-1052-z","article-title":"Botulinum neurotoxin type A in the treatment of classical trigeminal neuralgia (BoTN): study protocol for a randomized controlled trial","volume":"16","author":"Burmeister","year":"2015","journal-title":"Trials"},{"key":"R17-39-20210309","first-page":"4","article-title":"Botulinum toxin in trigeminal neuralgia: Which is the best way of delivery?","volume":"5","author":"Batifol","year":"2016","journal-title":"J Spine Neurosurg"},{"key":"R18-39-20210309","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1129-2377-14-92","article-title":"Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?","volume":"14","author":"Shehata","year":"2013","journal-title":"J Headache Pain"},{"key":"R19-39-20210309","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1129-2377-15-65","article-title":"Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Zhang","year":"2014","journal-title":"J Headache Pain"},{"key":"R20-39-20210309","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s10194-016-0651-8","article-title":"Therapeutic efficacy and safety of botulinum toxin A therapy in trigeminal neuralgia: a systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Morra","year":"2016","journal-title":"J Headache Pain"},{"key":"R21-39-20210309","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","article-title":"Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A","volume":"186","author":"Matak","year":"2011","journal-title":"Neuroscience"},{"key":"R22-39-20210309","doi-asserted-by":"crossref","first-page":"e29803","DOI":"10.1371\/journal.pone.0029803","article-title":"Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy","volume":"7","author":"Filipovi\u0107","year":"2012","journal-title":"PLoS One"},{"key":"R23-39-20210309","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","article-title":"Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy","volume":"44","author":"Durham","year":"2004","journal-title":"Headache"},{"key":"R24-39-20210309","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1242\/jcs.012211","article-title":"Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential","volume":"120","author":"Meng","year":"2007","journal-title":"J Cell Sci"},{"key":"R25-39-20210309","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1523\/JNEUROSCI.5490-08.2009","article-title":"Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential","volume":"29","author":"Meng","year":"2009","journal-title":"J Neurosci"},{"key":"R26-39-20210309","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0021-5155(99)00197-5","article-title":"Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles","volume":"44","author":"Ishikawa","year":"2000","journal-title":"Jpn J Ophthalmol"},{"key":"R27-39-20210309","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0304-3940(95)11889-5","article-title":"Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin","volume":"197","author":"Carlton","year":"1995","journal-title":"Neurosci Lett"},{"key":"R28-39-20210309","first-page":"831094","article-title":"Role of botulinum toxin type-A (BTX-A) in the management of trigeminal neuralgia","volume":"2013","author":"Verma","year":"2013","journal-title":"Pain Res Treat"},{"key":"R29-39-20210309","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1007\/s00415-004-1102-z","article-title":"Neurobiological basis for the use of botulinum toxin in pain therapy","volume":"251","author":"Mense","year":"2004","journal-title":"J Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:34:35Z","timestamp":1620959675000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201709290-00039"}},"subtitle":["6-Month follow-up"],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":29,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008133","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}